Pharmena S.A. (WSE:PHR)
3.080
+0.100 (3.36%)
Dec 5, 2025, 4:26 PM CET
Pharmena Market Cap
Pharmena has a market cap or net worth of 34.3 million as of December 5, 2025. Its market cap has decreased by -37.14% in one year.
Market Cap
34.30M
Enterprise Value
34.13M
Revenue
1.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.08
Market Cap Chart
Since August 25, 2008, Pharmena's market cap has decreased from 171.99M to 34.30M, a decrease of -80.05%. That is a compound annual growth rate of -8.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 34.30M | -19.58% |
| Dec 30, 2024 | 42.66M | -46.06% |
| Dec 29, 2023 | 79.08M | 26.79% |
| Dec 30, 2022 | 62.37M | -29.20% |
| Dec 30, 2021 | 88.10M | -10.89% |
| Dec 30, 2020 | 98.86M | 67.91% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.66B |
| NEUCA | 3.70B |
| Synektik Spólka Akcyjna | 2.37B |
| Voxel | 1.40B |
| Celon Pharma | 1.14B |
| Selvita | 870.05M |
| Ryvu Therapeutics | 670.48M |
| Centrum Medyczne ENEL-MED | 509.05M |